Over 12 months, Corbus Pharmaceuticals Holdings, Inc. saw more selling than buying from its insiders — purchases of about $126,000 against sales of $1.7 million.
Biggest single buyer: Saxena Nishant C, Executive Officer, with roughly $68,000.
107 investment managers listed CRBP in their latest 13F filings (Q2 2026); funds were split between buying and selling. Last full quarter: net selling by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Ben Yong | Director | Sell | 2,000 | $7.84 | $16K | SEC |
| Aug 12, 2026 | Saxena Nishant C | Executive Officer | Buy | 2,600 | $9.63 | $25K | SEC |
| Aug 10, 2026 | Cohen Yuval | CEO | Sell | 17,000 | $10.08 | $171K | SEC |
| Aug 10, 2026 | Moran Sean F. | CFO | Sell | 12,000 | $10.08 | $121K | SEC |
| Jun 11, 2026 | Kung Winston | Director | Sell | 2,026 | $7.91 | $16K | SEC |
| Jun 11, 2026 | Jenkins John Kenneth | Director | Sell | 4,800 | $7.91 | $38K | SEC |
| Jun 11, 2026 | Altmeyer Anne | Director | Sell | 2,412 | $7.91 | $19K | SEC |
| Jun 3, 2026 | Saxena Nishant C | Executive Officer | Buy | 4,500 | $7.33 | $33K | SEC |
| Jun 3, 2026 | Saxena Nishant C | Executive Officer | Buy | 9,000 | $7.58 | $68K | SEC |
| Mar 4, 2026 | Smethurst Dominic | Executive Officer | Sell | 6,097 | $8.30 | $51K | SEC |
| Feb 18, 2026 | Hodgson Ian | COO | Sell | 847 | $7.38 | $6K | SEC |
| Feb 18, 2026 | Moran Sean F. | CFO | Sell | 4,701 | $7.78 | $37K | SEC |
| Feb 18, 2026 | Cohen Yuval | CEO | Sell | 13,871 | $7.78 | $108K | SEC |
| Feb 4, 2026 | Smethurst Dominic | Executive Officer | Sell | 3,285 | $8.09 | $27K | SEC |
| Feb 4, 2026 | Hodgson Ian | COO | Sell | 2,415 | $8.09 | $20K | SEC |
In the last 12 months Corbus Pharmaceuticals Holdings, Inc. insiders made open-market purchases worth about $126,000 and sales worth about $1.7 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CRBP was filed on 2026-09-15.
107 investment managers reported holding CRBP in SEC Form 13F filings for Q2 2026.
No congressional trades in CRBP were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).